Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
2022年4月1日 - 6:42AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
001-39545
(Commission File Number)
Orphazyme A/S
in restructuring
(Exact name of registrant as specified in its charter)
Ole Maaløes Vej 3, DK-2200
Copenhagen N
Denmark
Tel: +45 39178272
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
American Depositary Shares, each representing one ordinary share, DKK 1 nominal value per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1) |
|
☐ |
Rule 12g-4(a)(2) |
|
☐ |
Rule 12h-3(b)(1)(i) |
|
☒ |
Rule 12h-3(b)(1)(ii) |
|
☐ |
Rule 15d-6 |
|
☐ |
Approximate number of holders of record as of American Depositary Shares as of the certification or notice date: 25
Pursuant to the requirements of the Securities Exchange Act of 1934, Orphazyme A/S in restructuring has
caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
Date: March 31, 2022 |
|
ORPHAZYME A/S in restructuring |
|
|
|
|
|
|
|
|
By: |
|
/s/ Anders Vadsholt |
|
|
|
|
|
|
Anders Vadsholt |
|
|
|
|
|
|
Chief Executive Officer and Chief Financial Officer |
ii
Orphazyme A S (CE) (USOTC:OZYMF)
過去 株価チャート
から 8 2024 まで 9 2024
Orphazyme A S (CE) (USOTC:OZYMF)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Orphazyme A S (CE) (その他OTC): 0 recent articles
その他のOrphazyme A/sニュース記事